Anti-angiogenic agent-associated adrenal insufficiency in immune checkpoint inhibitors-treated patients

被引：3
|
作者：
Guo, Qixiang [1 ]
Lu, Wenchao [1 ]
Sun, Ximu [2 ]
Zhao, Zhixia [1 ]
Liu, Lihong [3 ]
机构：
[1] Capital Med Univ, Beijing Chaoyang Hosp, Dept Pharm, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Pharm, Beijing, Peoples R China
[3] China Japan Friendship Hosp, Dept Pharm, Beijing, Peoples R China
来源：
EUROPEAN JOURNAL OF CANCER | 2021年 / 157卷
关键词：
D O I：
10.1016/j.ejca.2021.08.038
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：358 / 360
页数：3
相关论文
共 50 条
  • [21] Immune checkpoint inhibitor-associated primary adrenal insufficiency
    Reactions Weekly, 2022, 1918 (1) : 11 - 11
  • [22] Incidence and characteristic of adrenal insufficiency due to immune checkpoint inhibitors therapy
    Etoh, D.
    Harada, T.
    Shimauchi, A.
    Ibusuki, R.
    Kayukawa, T.
    Okamatsu, Y.
    Inoue, K.
    Tsubouchi, K.
    ANNALS OF ONCOLOGY, 2019, 30
  • [23] Effects of combining immune checkpoint inhibitors and anti-angiogenic agents on bone metastasis in non-small cell lung cancer patients
    Xie, Xiaohong
    Zhou, Maolin
    Wang, Liqiang
    Wang, Fei
    Deng, Haiyi
    Yang, Yiling
    Sun, Ni
    Li, Ru
    Chen, Ying
    Lin, Xinqing
    Liu, Ming
    Zhou, Chengzhi
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
  • [24] Rhinitis and epistaxis in patients treated by anti-angiogenic therapy
    V. Prulière-Escabasse
    E. Escudier
    R. Balheda
    J. C. Soria
    A. Coste
    C. Massard
    Investigational New Drugs, 2009, 27 : 285 - 286
  • [25] Rhinitis and epistaxis in patients treated by anti-angiogenic therapy
    Pruliere-Escabasse, V.
    Escudier, E.
    Balheda, R.
    Soria, J. C.
    Coste, A.
    Massard, C.
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (03) : 285 - 286
  • [26] Thromboembolic Events in Patients Treated with Anti-Angiogenic Drugs
    Ferroni, Patrizia
    Formica, Vincenzo
    Roselli, Mario
    Guadagni, Fiorella
    CURRENT VASCULAR PHARMACOLOGY, 2010, 8 (01) : 102 - 113
  • [27] Adrenal Insufficiency Immune checkpoint inhibitors and immune-related adverse event management
    Hobbs, Kiera B.
    Yackzan, Susan
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2020, 24 (03) : 240 - 243
  • [28] To be or not to be: whether anti-angiogenic agent combined with immune checkpoint inhibitoris necessary in the treatment of advanced or metastatic renal cell carcinoma
    Sun, Leitao
    Zhang, Leyin
    Yu, Jieru
    Zhou, Yiwen
    Shi, Chao
    Wasan, Harpreet S.
    Ruan, Shanming
    Huang, Dawei
    MEDICAL ONCOLOGY, 2020, 37 (02)
  • [29] To be or not to be: whether anti-angiogenic agent combined with immune checkpoint inhibitoris necessary in the treatment of advanced or metastatic renal cell carcinoma
    Leitao Sun
    Leyin Zhang
    Jieru Yu
    Yiwen Zhou
    Chao Shi
    Harpreet S. Wasan
    Shanming Ruan
    Dawei Huang
    Medical Oncology, 2020, 37
  • [30] Efficacy and safety of radiotherapy combined with anti-angiogenic therapy and immune checkpoint inhibitors in MSS/pMMR metastatic colorectal cancer
    Zhai, Menglan
    Zhang, Zixuan
    Wang, Haihong
    Ren, Jinghua
    Zhang, Sheng
    Li, Mingjie
    Liu, Lichao
    Li, Lisha
    Zhang, Lan
    Li, Xin
    Zhang, Tao
    Lin, Zhenyu
    CANCER MEDICINE, 2024, 13 (01):
12345